Alira Health Announces it Role as Strategic Advisor to Montagu Private Equity

Publications January 19, 2023

Medical Device Regulation in 2023: A Window of Opportunity

We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.

Medical Devices MedTech Regulatory

Publications January 19, 2023

What’s Next for Diabetes: Patient Engagement, Personalization, and Usable Technology

Alira Health partnered with the ADA to support this conversation and explore the most important topics emerging from patients, physicians, specialists, and patient advocates including(...)

Clinical Trials Diabetes MedTech Patient Engagement

Publications January 17, 2023

Insights on the MedTech Industry

In 2023, the MedTech industry will seek to turn the challenges of disruption into opportunities for lasting transformation. Discover the three keys that a successful MedTech company(...)

Healthcare Technology MedTech Patient Engagement

Events January 11, 2023

MD&M West 2023

Join our colleague Carlo Stimamiglio for his presentation “MedTech CDMO: Market and M&A Trends in 2023”, as he goes over key takeaways from our upcoming 2023 US MedTech CDMO Report.

CDMO MedTech

Publications December 21, 2022

2022 Recap: Your Favorite Alira Health Publications

In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)

Clinical Digital Health Market Access MedTech Pharma Regulatory

Publications December 13, 2022

Strategic Planning for Robotic-Assisted Surgery Solutions: A Framework for Success 

The robotic market can be segmented around many axes... Finding the right positioning requires continuous scanning of the market to optimize the chances of commercial success.

Medical Robotics MedTech

Publications December 6, 2022

Review of 2021-22 and 2023 Outlook: Report on the European MedTech CDMO Industry

A return to normalcy has accelerated growth for Europe’s MedTech CDMO industry, but individual companies may be at risk given the increased competitive pressure, logistics disruption,(...)

CDMO MedTech